# Top 50 Medical Angel Investors in United Kingdom in May 2026

## Jonathan Milner
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 8
- Stages: Seed, Series A, Series B
- Focus: Biotechnology, Health Care, Medical

Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is a Non-Executive Director of Horizon DiscoveryGroup plc, The Evolution Education Trust, GeoSpock Ltd and Sydicate Room Group Ltd. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Repositive Limited, Definigen Limited and Cambridge Allergy Ltd. Jonathan holds an executive director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP. Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three AIM IPOs.

## Mark Bamforth
- Type: Angel
- Location: Boston, Massachusetts, United States
- Relevant deals: 3
- Stages: Series A, Series B
- Focus: Medical, Health Care, Biotechnology

Mark Bamforth is the Operating Partner at Ampersand Capital Partners.

## Ian Hogarth
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, E-Commerce, Health Care

Ian got a master's in machine learning at Cambridge and loves dystopian robot takeover narratives. Seven years ago, Ian realized being a choirboy came with no street cred, so he started DJing hip-hop, funk, drum & bass, and grime. Ian quit his job at Bain & Company, Singapore to start Songkick.

## Matt Clifford
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, FinTech, SaaS

Matt co-founded EF after being a consultant at McKinsey & Co. Prior to EF Matt spent his time studying at MIT fuelled by an obsession with R, Python and unusual datasets. EF is the best place for Europe’s top technical individuals to meet and build world-changing startups in London.They select purely on the basis of technical talent, so youcan apply before you have a team or an idea. The intensive 6-month programme is designed to give you the best possible support in the first 200 days of your startup’s life.They have created over 40 startups now worth over $300 million. The startups are funded by some prestigious investors including Balderton Capital, Index Ventures, Octopus Investments and Y Combinator.

## Ariel Poler
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 2
- Stages: Seed, Series A, Angel
- Focus: Software, Social Media, Internet

Ariel Poler is the Co-Founder of Reveri Health. Ariel is an Internet entrepreneur, mentor, and investor. He was the founder of IPRO, the first web analytics company, and of Topica, one of the first email communities. Ariel was a board member of Kana Software, LinkExchange, Odeo, LOLapps, and StumbleUpon. He currently serves on the boards of FreedomFinancial Network, MixTent, Strava, and Scan Inc. Ariel’s angel investments include AdMob, Flixster, Slideshare, Xobni, RockYou, and Outright, BrightRoll, Instructables, Causes, Kongregate and NexTag. Ariel holds a B.S. in Mathematics with Computer Science from MIT and an MBA from Stanford University. He is originally from Venezuela and lives in San Francisco with his wife and three children.

## Taavet Hinrikus
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: FinTech, Financial Services, Software

Taavet Hinrikus is co-founder and CEO of TransferWise. Prior to starting TransferWise, Taavet was Skype’s director of strategy until 2008, starting as its first-ever employee. One of the World Economic Forum's Tech Pioneers, Taavet is an adviser to Prime Minister of Estonia on the digital agenda. He’s also a mentor and angel investor; hisinvestments include Tweetdeck, Mendeley, OMGPOP, Property Partner, Sunrise, Improbable and Mapillary.

## Richard Reed
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Pharmaceutical, Mobile, Content

Richard is the founder of Innocent Drinks, UK's number 1 smoothie brand. In 2009 The Coca-Cola Company acquired a minority stake in Innocent Drinks and in 2013 the stake was increased to over 90%. Innocent Drinks gives 10% of its profits to charity. Richard is known to have implemented a google-like working atmosphere at InnocentDrinks' offices, where people feel like at home. He appeared in sereval high profile TV shows and documentaries, here is a documentary with Peter Jones from Drangon's Den (UK's equivalent of Shark Tank) He is now a successful investor through his company JamJar Investments, where they invest in strong teams with an idea that consumers love.

## Matt Robinson
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, FinTech, Financial Services

Matt Robinson is the CEO and a co-founder at Nested, a property technology company. Prior to this, he founded GoCardless in 2010 and remains on the board of the recurring payment company.

## Nicholas Edwards
- Type: Angel
- Location: Oxford, Oxfordshire, United Kingdom
- Relevant deals: 2
- Stages: Seed
- Focus: Medical, Health Care, Life Science

Nick serves as the Chairman of Prescient’s Board of Directors. He holds a degree in physiological sciences from The Queen’s College, University of Oxford, and completed his training in clinical medicine (BM, BCh) at Green College (now Green Templeton College), University of Oxford. Nick practiced in the areas of cardiology and general surgerybefore joining Andersen Consulting (now known as Accenture), eventually becoming the global leader of Accenture’s pharmaceutical R&D business during his 18-year tenure. In 2005, he founded Kinapse to provide consulting and outsourcing services to the pharmaceutical industry. Nick served as Kinapse’s Chairman until the company was sold to HgCapital in early 2016.

## Will Martin
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: FinTech, Financial Services, Software

Will Martin - Founder and Director @ Portfolio Ventures

## Alexander Edward Chesterman
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: E-Commerce, FinTech, Financial Services

Alex Chesterman is the founder and CEO of Cazoo. He was the Founder & CEO of ZPG Plc, a FTSE-250 listed company.
Previously Alex co-founded Lovefilm, Europe's leading digital movie rental business, which was successfully sold to Amazon. Alex is also one of the UK's most active tech angel investors having backed dozens of early stagedigital startups and was awarded an OBE for services to services to digital entrepreneurship in 2016.

## Jan Hruska
- Type: Angel
- Relevant deals: 2
- Stages: Seed
- Focus: Medical, Health Care, Life Science

Jan Hruska

## Will Brooks
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Financial Services, FinTech, Software

Will Brooks - Founder & Director @ Portfolio Ventures

## Michael Pennington
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, Financial Services

One of the UK's leading tech angel investors. Active seed and pre-seed stage angel investor in UK based disruptive tech. Prefers businesses venturing into pastures new and keen investing at the pre product stage whether BtoC or B2B.
Twice exited UK based tech entrepreneur with experience operating tech businesses in 20 countries in multiplelanguages. Co-founded Gumtree with Simon Crookall which was acquired by Ebay and Slando acquired by Naspers.

## Adam Niewinski
- Type: Angel
- Location: Warsaw, Mazowieckie, Poland
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: FinTech, Financial Services, Artificial Intelligence

Co-Founder and General Partner in OTB Ventures Graduated from the Warsaw School of Economics and is also Alumni of Stanford University - Graduate School of Business. Founder and CEO of Expander (Poland) as well as Co-Founder of Platinum Bank (Ukraine). Adam Niewiński started his professional career in 1997 at The Boston Consulting Group where heworked as a consultant specialized in financial services sector. As of 2000 he was building a team, acquired financing and subsequently established Expander, which became probably the first polish FinTech. Since 2002 up till 2017 had been associated with the UniCredit Group where he started working in the Central Brokerage House of Bank Pekao S.A. as Deputy CEO responsible for all business activities (investment banking and wealth management). Next, he became CEO of Xelion Investment House – a failed corporate start up that he successfully relaunched to become a leading platform for Personal Financial Advisers with $1b of AuA. In 2015 he was appointed Deputy CEO of Bank PEKAO SA responsible for Private Banking Division as well as Small and Mid Corpo acquisition and financing. He was also the Chairman of the Supervisory Board of Xelion Investment House, Chairman of the Supervisory Board of Private Equity Managers, Deputy Chairman of the Supervisory Board of Central Brokerage House of Bank Pekao S.A., Member of the Supervisory Board of Pekao Investment Banking, and Member of the Management Board of the Society for the Encouragement of Fine Arts by the Zachęta Gallery – National Gallery of Art.

## Roger Hassan
- Type: Angel
- Location: Ilford, Redbridge, United Kingdom
- Relevant deals: 1
- Stages: Angel, Pre-Seed
- Focus: Grocery, Medical, Wellness

Roger Hassan is the Founding Partner at Shorea Ventures.

## Brian Kennedy
- Type: Angel
- Relevant deals: 1
- Stages: Angel
- Focus: Music, Medical, Commercial

Brian Kennedy

## Pa Nolan
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Delivery, Shipping

Pa Nolan

## Carlos Gallardo
- Type: Angel
- Location: Barcelona, Catalonia, Spain
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Health Care, Medical Device, Medical

Carlos Gallardo

## John Lloyd
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Equity Crowdfunding
- Focus: Health Care, Education, Wellness

John Lloyd

## Jim Mellon
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Pharmaceutical

Jim Mellon

## Mark P. Stevenson
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Genetics, Health Care

Life Sciences Investor & Board member | Former EVP & COO Thermo Fisher Scientific

## Evelyn Bourke
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series B
- Focus: InsurTech, Insurance, Software

Evelyn was appointed Bupa’s Group CEO in July 2016, having been Acting Group CEO from April 2016. She is also a member of the Bupa Board and Nomination & Governance Committee.She has a strong track record in global executive management and extensive experience in financial services, risk and capital management, and mergers and acquisitions.Evelyn joined Bupa as CFO in September 2012, from Friends Life where she was Chief Executive Officer of its Heritage division. Previously at Friends Provident, she was the Executive Director responsible for strategy, capital and risk and, before that, Chief Financial Officer.Evelyn grew up on a dairy farm in Ireland and she’s the eldest of six. She was one of the first two women in Ireland to qualify as actuaries. She began her career with New Ireland Assurance and Bank of Ireland. She holds an MBA from London Business School and was previously a Non-Executive Director of the IFG Group in Ireland. Evelyn is currently a Non-Executive Director of the Bank of Ireland Group plc and a member of their Audit Committee and Nomination and Governance Committee.On becoming Group CEO in April 2016, Evelyn established a clear Strategic Framework to focus the organisation on delivering for customers.Evelyn believes strongly in promoting diversity in the workplace and empowering people to deliver high standards of service and care for customers.

## Tracy Doree
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed
- Focus: FinTech, Medical, Wellness

Tracy Dorée is a Founding Partner Kindred Capital. Tracy Dorée is the Co-Founder of Fab UK and serves as its Chief Executive Officer. She serves as Senior Vice President of Merchandising & Design for Europe at Fab, Inc. Tracy Dorée serves as an Investment Manager at MMC VENTURES Ltd. She joined MMC VENTURES in 2008 and is a Member of Investmentteam. Tracy Dorée is responsible for sourcing and executing new investments and managing individual portfolio companies. Prior to this, she gained experience in investment banking at NM Rothschild and strategy consulting at Accenture. Tracy Dorée served as Non-Executive Director of Base79 Limited. She holds a M.A. in Mathematics (first) from Balliol College, Oxford University.

## Reece Chowdhry
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Equity Crowdfunding
- Focus: Software, Financial Services, FinTech

Reece is the Founder & CEO of RLC Ventures - an early-stage SEIS/EIS VC fund investing in technology companies primarily focused on Fintech, Enterprise and Gaming. He was awarded “Top 5 Asian Tech Investors” 2018 (KPMG & Diversity UK) and is the youngest-ever investor to profiled by The Sunday Times. Reece is a frequent keynote andpanel speaker at prominent industry events such as StartupGrind Europe and Fintech Live. Reece holds a BA in International Business from Durham University and is a Chartered Management Consultant (ACMA, CGMA) having started his career as a Management Consultant at EY.Reece invests personally in all of RLC Ventures' investments.

## Fred Moll, M.D
- Type: Angel
- Location: San Francisco Bay Area, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Medical Device, Health Care, Medical

Frederic H. Moll, M.D. serves as Chief Development Officer of Johnson & Johnson’s Digital Surgery Group. Prior to Johnson & Johnson, Dr. Moll was CEO of Auris Health, Inc., located in Redwood City, California. Prior to Auris, Dr. Moll founded Hansen Medical and served as the company’s first CEO, and in 1995, founded Intuitive Surgical,Inc. (Nasdaq: ISRG).Dr. Moll earned a M.D. from the University of Washington, School of Medicine, a M.S. degree in Management from Stanford University’s Sloan Program, and a B.A. degree from the University of California at Berkeley.

## Mark Cuban
- Type: Angel
- Location: Dallas, Texas, United States
- Relevant deals: 1
- Stages: Seed, Series A, Angel
- Focus: Blockchain, Software, E-Commerce

Mark Cuban is the founder of Fireside, Chairman and Founding partner of AXS TV, and the Owner of Dallas Mavericks. Prior to that, he was the Co-Founder of Broadcast.com. Mrk attended the Indiana University Bloomington.

## Jonathan Lenson
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Grant, Pre-Seed
- Focus: Software, Information Technology, Internet

Jonathan Lenson

## Catherine Lenson
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Grant, Pre-Seed
- Focus: Software, Information Technology, Internet

Catherine is an investor, board director and executive coach. She is based in London and works globally.She is an experienced international C-suite executive with a strong track record in the People, DE&I and ESG fields. Together with Jonathan Lenson. she invests in exceptional early-stage tech companies across the UK, US and Israel, andbrings in-depth previous board experience as both an executive and non-executive director.She writes and speaks on topics including the future of work, corporate culture and purpose, diversity and inclusion, and work/life integration.As part of her coaching practice, she is the first UK-based facilitator to be certified in the Fair Play method. Catherine was the first female Managing Partner appointed at SoftBank Investment Advisers, the world’s largest technology investment firm with $175 billion under management in the two SoftBank Vision Funds and SoftBank Latin America Funds. As the founding Chief People Officer for five years (2017-2022), she led the HR, ESG and Real Estate teams globally.An experienced and trusted executive coach at C-suite level, she worked with companies within the Vision Fund portfolio on leadership, talent, DE&I, ESG, and operating challenges, including as a Board Director.Catherine built SBIA’s ESG practice and designed its strategy for Social Impact. She led SoftBank’s early stage venture funds focused on diverse founders, including the $100m+ SB Opportunity Fund (US) and Emerge (EMEA), including as an Investment Committee member.Catherine is a Young Global Leader of the World Economic Forum (Class of 2021) and a founding member of Sustainability30 (which brings together Chief Sustainability Officers from 30 of the world’s leading companies).She spent the formative years of her career at UBS AG, Switzerland’s leading financial services firm, and is proud to have progressed from intern to Managing Director in the same firm. In her final role there, she led Reward for UBS across the UK and EMEA region.

## Arjun Desai
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Medical Device

Dr. Desai brings a variety of medical industry, health policy, and clinical academic experiences to Avinger. Initially joining Avinger as a consultant in 2009, Dr. Desai helped to direct and publish the pivotal CONNECT study, which successfully established FDA clearance for Avinger’s Wildcat and Kittycat CTO crossing catheters. After joiningAvinger full time in 2012, Dr. Desai has expanded his focus to oversee health economics, reimbursement, clinical evidence generation, and scientific theory. In that time, Avinger has successfully published more than twenty manuscripts, clinical conference presentations, and case series. Most recently, Dr. Desai and his team successfully conducted and published the first ever peer reviewed Lumivascular manuscripts hallmarking a large European case series and the landmark CONNECT II clinical trial for the Ocelot catheter. Prior to Avinger, Dr. Desai served as a consultant and advisor for Incline Therapeutics, developing the IONSYS transdermal fentanyl delivery system. Additionally, Dr. Desai has consulted with pharmaceutical development targeting cancer therapeutics and healthcare IT development for capture of real time quality- metric assessment and implementation.Prior to management consulting, Dr. Desai served as a fellow in the US House Policy Committee, advising members of Congress on healthcare legislation. Additionally, Dr. Desai represented the US State Department and Rotary International as an Ambassador of Goodwill to Singapore where he led vaccine prophylaxis campaigns and lectured in the department of health economics at the National University of Singapore.Dr. Desai maintains his clinical practice as adjunct faculty at Stanford University in the department of Anesthesia where he completed his advanced anesthesia residency training. Dr. Desai holds an M.D. from the University of Miami Miller School of Medicine and a B.A. in Economics from the University of Oklahoma.

## Robert Taub
- Type: Angel
- Location: Brussels, Brussels Hoofdstedelijk Gewest, Belgium
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Biotechnology, Medical, Hospital

Robert Taub is the Co-Founder and Chairman at Nyxoah.

## Will Armitage
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: FinTech, Software, Health Care

William Armitage is the Co-Founder & CFO ,Advisor of The Game Day.

## Bob Davis
- Type: Angel
- Location: Cambridge, Massachusetts, United States
- Relevant deals: 1
- Stages: Series C, Series B, Series A
- Focus: Internet, E-Commerce, Social Network

Bob Davis is a General Partner at Highland Capital Partners and an Executive Chairman at Highland Transcend Partners. He was a CEO at Lycos. Bob attended Northeastern University and Babson College.

## Jon Moulton
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: Financial Services, FinTech, Banking

Jon Moulton is a British venture capitalist. He is the founder and managing partner of the private equity firm Better Capital, and is the former managing partner of the private equity firm Alchemy Partners.

## Imran Hakim
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Medical Device

Imran Hakim, Optometrist, Inventor, and Serial Entrepreneur.

## Brian Souter
- Type: Angel
- Location: Edinburgh, Edinburgh, City of, United Kingdom
- Relevant deals: 1
- Focus: Medical, Commercial, Health Care

Sir Brian Souter is co-founder and Chairman of Stagecoach plc, having retired as Chief Executive in May 2013.Whilst he does not sit with the Souter Investments team in Edinburgh, Sir Brian is active in all investment decision making processes and sits on the boards of our European bus operators (PolskiBus.com and OnniBus.com) and New Zealandtransport group (InMotion).Sir Brian is currently the Vice-President of the Institute of Chartered Accountants of Scotland.

## Henry Carleton
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Health Diagnostics

Henry is a trained doctor with extensive hospital experience who co-founded Four Eyes Insight to put his talent for finding strategic solutions and planning into helping the NHS.His interest in medical resource management developed during his junior doctor training at Bart’s and the Royal London and he helped trusts tackle the significantchallenges of rotas and the New Deal as Junior Doctors’ Advisor at the London Regional Action Team.Establishing Zircadian Ltd, a software development company focusing on a portfolio of solutions to help NHS organisations plan and organise their medical workforce more strategically and effectively in 2000, he sold it on 11 years later to Allocate with over 140 NHS clients using its products.

## Robert Marshall
- Type: Angel
- Location: Cambridge, Cambridgeshire, United Kingdom
- Relevant deals: 1

Robert Marshall is Executive Chairman of Martlet Capital.

## Mark McCamish
- Type: Angel
- Location: Ventura, California, United States
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Biopharma, Biotechnology

Dr. McCamish is President and Chief Executive Officer of IconOVir Bio. Previously he was President and Chief Executive Officer of Forty Seven, Inc. He led Forty Seven, Inc. during critical phases of clinical development to help patients defeat their cancer. This included growing from a valuation of $169 million as a private company through a SeriesB offering, Initial Public Offering, two secondary fund raises and finally the acquisition of Forty Seven by Gilead for $4.9 Billion.He is an international expert in biologic and biosimilars development and manufacturing. Mark is passionate about mentoring and developing people while focusing on meeting patient needs through efficient, commercially viable efforts. He is a senior executive with extensive experience at multiple companies including Abbott, Amgen, and Novartis/Sandoz. He led pioneering efforts in filing/launching biosimilars worldwide. He has demonstrated a commercial mindset in establishing research and development strategies leading to approvals and commercial success in multiple therapeutic areas and regulatory categories including biologics, biosimilars, drugs, devices, and medical foods.He received Bachelor’s and Master’s degrees from UCSB and, after completing his PhD in Human Nutrition from Penn State and MD from UCLA, he completed Residency and Fellowship Training at the University of California, Davis. He held professorships at UC Davis and The Ohio State University

## Curtis Chambers
- Type: Angel
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: Internet, GPS, Marketplace

Curtis Chambers

## Stephen Bourke
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Pre-Seed, Angel
- Focus: Health Care, Medical, Wellness

Stephen Bourke

## Errol Damelin
- Type: Angel
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Seed, Series A, Pre-Seed
- Focus: FinTech, Financial Services, Finance

Errol Damelin is the Founder, CEO, chairman, or original investor and backer of over 75 digital and tech companies around the world, including in the US, the UK, most of Europe, Israel, Indonesia, Brazil, Turkey, South Africa, and Nigeria. He concentrates his efforts on SaaS, fintech, crypto, marketplaces and data analytics as well as on health andwellness. He is also a technologist and has three granted patents to his name with another four pending.Among the companies co-founded by Damelin are groundbreaking fintech company Wonga, and SME banking startup Tide. His early investments include Wise, Cazoo, Purplebricks, K Health, YuLife, Sure, Demyst, Zoe, Farewill, CityMapper, Modifi, UnBabel, Thimble, HiBob, Modifi, Elliptic, Lendingkart, and VivaReal.
Using his own personal equity, Damelin continues to invest early on in the next generation of entrepreneurs so that he can help them succeed. He is not an institutional VC fund and does not maximize the assets under his management. He best describes his approach as Riding Shotgun.Damelin's success as a founder has been recognized by The Guardian, which named him Digital Entrepreneur of the Year in 2011; by Ernst and Young, which named him the UK's Entrepreneur of the Year in 2011 as well; and by TechCrunch, which named him Founder of the Year in 2010.

## Inaki Berenguer
- Type: Angel
- Location: New York, New York, United States
- Relevant deals: 1
- Stages: Seed, Angel, Pre-Seed
- Focus: E-Commerce, FinTech, Enterprise Software

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

## Sachin Agrawal
- Type: Angel
- Relevant deals: 1
- Stages: Series A
- Focus: Medical, Health Care, Health Diagnostics

Sachin Agrawal

## Holly Branson
- Type: Angel
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Medical, Incubators, Electronics

Holly Branson

## Elan Katz
- Type: Angel
- Relevant deals: 1
- Stages: Seed
- Focus: Medical, Health Care, Medical Device

Elan Katz, CEO at Quick RX.

## Jim Breyer
- Type: Angel
- Location: Menlo Park, California, United States
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Health Care, Financial Services, Software

Jim Breyer - Co-Founder @ Accel-KKR

## Brendan O'Driscoll
- Type: Angel
- Location: Los Angeles, California, United States
- Relevant deals: 1
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Wellness, Artificial Intelligence

Brendan O'Driscoll is the Chief Product Officer of KOHO.

## Henry Engelhardt
- Type: Angel
- Relevant deals: 1
- Stages: Series A, Debt Financing
- Focus: Medical, Health Care, Collaboration

Henry Engelhardt

## Paul Roy
- Type: Angel
- Location: Zolwia Bloc, Zachodniopomorskie, Poland
- Relevant deals: 1
- Stages: Seed
- Focus: Fitness, Medical, Wellness

He was a founding partner and chairman of NewSmith Asset management, a fund manager for a wide range of institutional, pension fund and high net worth investors. Having started his career at the stockbroking firm Kemp Gee he subsequently became senior partner following the merger with Scrimgeour Vickers and Citibank. In 1988 he joined Smith Newcourt, the leading market making firm on the London Stock Exchange and as CEO, together with chairman Michael Marks merged the business with Merrill Lynch in 1995. At Merrill, Paul held a number of senior positions including head of Global Equities and in 2001 was made EVP and president of Merrill Lynch Global Markets and investment banking, responsible for the firm’s investment banking, debt and equity business worldwide. He left Merrill in 2003 to start NewSmith.He has served as a non executive director of Benfield plc and Cenkos securities and is currently Chairman of New River Retail plc the leading UK REIT specialising in retail property investment.Between 2007 and 2013 Paul served two terms as Chairman of the newly created British Horse Racing Authority, responsible for the Governance and Regulation of the country’s second largest sport. He is now Chairman of ROR, the sports main charity, responsible for ensuring that horses are cared for, retrained, and re-homed, after their racing careers are over.
He has a Bachelor of Arts (Honours) degree in Economics from Liverpool University and in 2009 was awarded an Honoury Doctorate of Law from Liverpool University.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co